<DOC>
	<DOCNO>NCT01585181</DOCNO>
	<brief_summary>The purpose study compare safety immunogenicity single dose PXVX0200 live cholera vaccine versus placebo volunteer ( Vaccinees ) whether PXVX0200 , live attenuate bacteria , transmit adult live household .</brief_summary>
	<brief_title>Safety Immunogenicity Live Oral Cholera Vaccine Candidate PXVX0200</brief_title>
	<detailed_description>Approximately 60 subject 120 household contact enrol United States . Vaccinees randomly assign receive either PXVX0200 placebo 5:1 ratio follow 180 day postdose .</detailed_description>
	<mesh_term>Cholera</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy Men woman , age 18 50 year ( inclusive ) without significant medical history , physical clinical lab abnormality ( per protocol define range ) Women childbearing potential must negative urine pregnancy test must willing use adequate birth control 2 month follow vaccination additional pregnancy test indicate Vaccinees must live alone two household contact willing sign inform consent participate study Household contact must healthy ( base medical history ) men woman age 1865 year ( inclusive ) Healthcare worker direct contact patient immunodeficient , HIVpositive , unstable medical condition age 18 Childcare worker direct contact child 2 year age young employ food service industry Resides HHCs age 18 age 65 Has abnormal stool pattern define few 3 stool per week 2 stool per day past 6 month Has know allergy , know medical condition precludes use tetracycline ciprofloxacin Previously receive licensed investigational cholera vaccine Has history cholera enterotoxigenic E. coli infection ( natural infection experimental challenge ) Travel choleraendemic area experience symptom consistent traveler 's diarrhea previous 5 year Received plan receive license vaccine 14 day prior study vaccination Day 28 Received plan receive antibiotic ( protocolspecified ) chloroquine within 14 day prior study vaccination Day 28</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Vaccine , Bacterial disease condition , Cholera</keyword>
</DOC>